Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

One fifth of UK consumers are likely to reduce or stop shopping online due to cyberattack concerns, says GlobalData

Concerns around cybersecurity are prompting a shift in online shopping behavior, particularly among younger consumers in the UK. With one third of 16-34s considering cutting back or stopping online purchases, retailers face rising pressure to reinforce digital trust. This is especially the case for online pureplays, which cannot redirect sceptical consumers to stores, according to […]
Read more

Fixed communication service revenue in Philippines to grow at 2.5% CAGR over 2024-2029, forecasts GlobalData

The total fixed communication services revenue in the Philippines is expected to increase at a compound annual growth rate (CAGR) of 2.5% from $3.6 billion in 2024 to $4.1 billion in 2029, mainly driven by the fixed broadband service segment, reveals GlobalData, a leading data and analytics company. GlobalData’s Philippines Fixed Communication Forecast (Q1 2025) […]
Read more

US tariffs prompt GlobalData to revise India economic growth forecast down to 6.5% in July 2025

Following the news that the US will impose 25% tariffs on all Indian imports starting from 1 August 2025; Ramnivas Mundada, Director of Economic Research and Companies at GlobalData, a leading data and analytics company, offers his view: “These significant tariffs, coupled with penalties linked to India’s dealings with Russian energy and military supplies, pose […]
Read more

World Hepatitis Day 2025: Renewed global push urgent need amid rising mortality, says GlobalData

World Hepatitis Day, observed each year on 28 July, highlights the urgent need to combat viral hepatitis—one of the world’s deadliest infectious diseases, impacting over 300 million people globally. Despite available vaccines and treatments, rising mortality and persistent systemic, financial, and social barriers underscore the critical importance of renewed global efforts toward hepatitis elimination by […]
Read more

China’s obesity market poised for takeoff with homegrown therapies and late-stage pipeline, says GlobalData

China has recently approved the first locally developed obesity drug “Xinermei (mazdutide),” marking a critical milestone in the country’s obesity treatment landscape. Backed by a robust late-stage pipeline and differentiated dual-receptor mechanisms, the domestic obesity therapeutics market is set for rapid expansion, driven by innovation, rising disease burden, and a shift toward more accessible, locally […]
Read more

Liquid risk forces insurers to reinvent operations and redefine protection, says Celent, a GlobalData company

In an era defined by continuous disruption and systemic uncertainty, the insurance industry stands at a pivotal moment. Traditional approaches to underwriting, pricing, and risk modelling are faltering in the face of climate change, technological disruption, geopolitical fragmentation, and social instability. Against this backdrop, the concept of Liquid Risk casts risk as dynamic, interconnected and […]
Read more

Diagnosed prevalent cases of HER2- breast cancer across 8MM set to reach 4.12 million in 2034, forecasts GlobalData

The burden of five-year diagnosed prevalent cases of HER2-Negative (HER2-) breast cancer is expected to increase at an annual growth rate (AGR) of 1.42% from around 3.61 million in 2024 to 4.12 million in 2034 across the eight major markets (8MM*), forecasts GlobalData, a leading data and analytics company. GlobalData’s latest report, “HER2-Negative Breast Cancer: […]
Read more

Semaglutide emerges as contender in cerebrovascular disease management, says GlobalData

Semaglutide, a GLP-1R agonist also known as Ozempic or Wegovy and initially developed for type 2 diabetes, is emerging as a promising candidate for neurological conditions. The recent clinical findings suggest its potential to improve outcomes in stroke and brain hemorrhage patients, driven by its cardiovascular and anti-inflammatory effects. These developments highlight a significant therapeutic […]
Read more

A&O Shearman top M&A legal adviser by value in automotive sector in H1 2025, CMS and Kirkland & Ellis lead by volume, reveals GlobalData

A&O Shearman was the top mergers and acquisitions (M&A) legal adviser in the automotive sector during the first half (H1) of 2025 by value, while CMS and Kirkland & Ellis jointly occupied the top position by volume according to the latest legal advisers league table by GlobalData, a leading data and analytics company. An analysis […]
Read more

US tariffs trigger supply chain reconfiguration and mark end of hyper globalization, says GlobalData

The US tariffs are accelerating the breakdown of hyper-globalization, forcing companies worldwide to rethink their supply chain strategies. As protectionist policies take hold, supply chains are shifting toward localization to mitigate risk and rising costs. Global trade is entering a new era, defined not by efficiency, but by resilience, regionalization, and strategic reconfiguration, says GlobalData, […]
Read more

ICP monitoring devices market grows modestly amid clinical reliance, limited innovation and access gaps, finds GlobalData

Intracranial pressure (ICP) monitoring devices remain essential in managing neurological emergencies, yet the market is maturing slowly amid limited innovation and entrenched clinical preferences. With annual growth at just 2.4%, the sector is shaped more by procedural reliability than technological disruption. Despite their proven value, broader adoption hinges on integrating innovation with clinical workflows and […]
Read more
1 … 25 26 27 28 29 … 209